~~<i id='41AC0BF68E'><strike id='41AC0BF68E'><tt id='41AC0BF68E'><pre id='41AC0BF68E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

comprehensive

author：focus 2025-09-14 21:44:25 - browse：76

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Drastic changes should bring profitability, startup health insurers say

entertainment

hotspot

focus

knowledge

hotspot

MicahCanvasser'stragicdeathonemonthbeforehisfirstbirthdayhasinspiredhismothertofightnecrotizingenter

WSS

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Ambulance rides for just $100? Advisers want major billing fixes

How to use technology to prevent future drug shortages

Why failed clinical trials don’t always spell doom for a new drug

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

STAT Executive Editor Rick Berke on STAT's 8th birthday

Wikipedia

comprehensive

entertainment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Extreme heat events are a public health emergency

George Santos makes 1st court appearance after pleading not guilty to 13 counts

American woman, child freed after being kidnapped in Haiti last month

Apple is now the first public company to be valued at $3 trillion

Man killed during FBI raid in connection with threats against Biden, other officials

Sports medicine is finally prioritizing gender equality

Naloxone nonprofit donates 200,000 doses after FDA approval

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Removing probiotics from the NICU could threaten preemies' health

hotspot

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

FDA panel issues narrow recommendation for Covid vaccine booster doses

Why failed clinical trials don’t always spell doom for a new drug

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Drastic changes should bring profitability, startup health insurers say

Biotech incubator Curie.Bio graduates its first startup

focus

knowledge

hotspot

hotspot